Troglitazone (Rezulin) [2] [9] and trovafloxacin (Trovan) are two prime examples of idiosyncratic hepatotoxins pulled from market
If you have heart symptoms, chest pain, or fainting, get urgent help.
Recommended EAS 2024 Anti-inflammatory therapies for CVD risk prevention Ulrich Laufs, MD, PhD Ulrich Laufs, MD, PhD EAS 2024 Novel PCSK9 inhibitor lowers LDL-c in another large phase 3 study Evan Stein, MD, PhD Evan Stein, MD, PhD EAS 2024 Causal relationship between elevated Lp(a) levels and CKD risk Anne Langsted, MD, PhD Anne Langsted, MD, PhD EAS 2024 LDL-c lowering with PCSK9 inhibitor in ASCVD patients without acute ischemic event Pasquale Perrone-Filardi, MD, PhD Pasquale Perrone-Filardi, MD, PhD
Side effects from these products can be unpredictable